1155PPhase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29 (suppl_8) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | suppl_8 |
| container_start_page | |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Tsimberidou, A-M Ma, H Stewart, C Schoor, O Maurer, D Mendrzyk, R Satelli, A Fritsche, J Stephens, G Mohamed, A Hwu, P Yee, C Reinhardt, C Weinschenk, T Gharpure, K Stungis, A Vining, D J Singh, H Walter, S Andersson, B S |
| description | |
| doi_str_mv | 10.1093/annonc/mdy288.028 |
| format | Article |
| fullrecord | <record><control><sourceid>oup</sourceid><recordid>TN_cdi_oup_primary_10_1093_annonc_mdy288_028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdy288.028</oup_id><sourcerecordid>10.1093/annonc/mdy288.028</sourcerecordid><originalsourceid>FETCH-oup_primary_10_1093_annonc_mdy288_0283</originalsourceid><addsrcrecordid>eNqVkE1OwzAQRi0EEuXnAOxmCYI0dtKUZFm1ILpA6qL7aJS4jZFjW_akkEtxiJ6MhHIBVqPRvO8b6TF2J_hU8CKN0Rhrqrit-yTPpzzJz9hEZPMiyvlMnLMJL5I0es7S2SW7CuGDcz4vkmLCjkJk2WbTYJCwBqytI3WQUEmtO40eqJEeXQ_kFWr4VNSA_IoO6mAhkGoHhmQN2JHVdm-7AMtV_gjbaCwIgHtUJhAMHCmnJRD6vaQA94vldkwcv2H9vhBcPIAy4JCUNMP594-XGl0Y200dWz_sO48VWd9DsFrVUKGppA837GKHOsjbv3nNnl5ftsu3yHaudF616PtS8HL0VJ48lSdP5eAp_Sf-A-y4dpA</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>1155PPhase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Tsimberidou, A-M ; Ma, H ; Stewart, C ; Schoor, O ; Maurer, D ; Mendrzyk, R ; Satelli, A ; Fritsche, J ; Stephens, G ; Mohamed, A ; Hwu, P ; Yee, C ; Reinhardt, C ; Weinschenk, T ; Gharpure, K ; Stungis, A ; Vining, D J ; Singh, H ; Walter, S ; Andersson, B S</creator><creatorcontrib>Tsimberidou, A-M ; Ma, H ; Stewart, C ; Schoor, O ; Maurer, D ; Mendrzyk, R ; Satelli, A ; Fritsche, J ; Stephens, G ; Mohamed, A ; Hwu, P ; Yee, C ; Reinhardt, C ; Weinschenk, T ; Gharpure, K ; Stungis, A ; Vining, D J ; Singh, H ; Walter, S ; Andersson, B S</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy288.028</identifier><language>eng</language><publisher>Oxford University Press</publisher><ispartof>Annals of oncology, 2018-10, Vol.29 (suppl_8)</ispartof><rights>The Author(s) 2018. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com. 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Tsimberidou, A-M</creatorcontrib><creatorcontrib>Ma, H</creatorcontrib><creatorcontrib>Stewart, C</creatorcontrib><creatorcontrib>Schoor, O</creatorcontrib><creatorcontrib>Maurer, D</creatorcontrib><creatorcontrib>Mendrzyk, R</creatorcontrib><creatorcontrib>Satelli, A</creatorcontrib><creatorcontrib>Fritsche, J</creatorcontrib><creatorcontrib>Stephens, G</creatorcontrib><creatorcontrib>Mohamed, A</creatorcontrib><creatorcontrib>Hwu, P</creatorcontrib><creatorcontrib>Yee, C</creatorcontrib><creatorcontrib>Reinhardt, C</creatorcontrib><creatorcontrib>Weinschenk, T</creatorcontrib><creatorcontrib>Gharpure, K</creatorcontrib><creatorcontrib>Stungis, A</creatorcontrib><creatorcontrib>Vining, D J</creatorcontrib><creatorcontrib>Singh, H</creatorcontrib><creatorcontrib>Walter, S</creatorcontrib><creatorcontrib>Andersson, B S</creatorcontrib><title>1155PPhase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqVkE1OwzAQRi0EEuXnAOxmCYI0dtKUZFm1ILpA6qL7aJS4jZFjW_akkEtxiJ6MhHIBVqPRvO8b6TF2J_hU8CKN0Rhrqrit-yTPpzzJz9hEZPMiyvlMnLMJL5I0es7S2SW7CuGDcz4vkmLCjkJk2WbTYJCwBqytI3WQUEmtO40eqJEeXQ_kFWr4VNSA_IoO6mAhkGoHhmQN2JHVdm-7AMtV_gjbaCwIgHtUJhAMHCmnJRD6vaQA94vldkwcv2H9vhBcPIAy4JCUNMP594-XGl0Y200dWz_sO48VWd9DsFrVUKGppA837GKHOsjbv3nNnl5ftsu3yHaudF616PtS8HL0VJ48lSdP5eAp_Sf-A-y4dpA</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Tsimberidou, A-M</creator><creator>Ma, H</creator><creator>Stewart, C</creator><creator>Schoor, O</creator><creator>Maurer, D</creator><creator>Mendrzyk, R</creator><creator>Satelli, A</creator><creator>Fritsche, J</creator><creator>Stephens, G</creator><creator>Mohamed, A</creator><creator>Hwu, P</creator><creator>Yee, C</creator><creator>Reinhardt, C</creator><creator>Weinschenk, T</creator><creator>Gharpure, K</creator><creator>Stungis, A</creator><creator>Vining, D J</creator><creator>Singh, H</creator><creator>Walter, S</creator><creator>Andersson, B S</creator><general>Oxford University Press</general><scope/></search><sort><creationdate>20181001</creationdate><title>1155PPhase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers</title><author>Tsimberidou, A-M ; Ma, H ; Stewart, C ; Schoor, O ; Maurer, D ; Mendrzyk, R ; Satelli, A ; Fritsche, J ; Stephens, G ; Mohamed, A ; Hwu, P ; Yee, C ; Reinhardt, C ; Weinschenk, T ; Gharpure, K ; Stungis, A ; Vining, D J ; Singh, H ; Walter, S ; Andersson, B S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-oup_primary_10_1093_annonc_mdy288_0283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tsimberidou, A-M</creatorcontrib><creatorcontrib>Ma, H</creatorcontrib><creatorcontrib>Stewart, C</creatorcontrib><creatorcontrib>Schoor, O</creatorcontrib><creatorcontrib>Maurer, D</creatorcontrib><creatorcontrib>Mendrzyk, R</creatorcontrib><creatorcontrib>Satelli, A</creatorcontrib><creatorcontrib>Fritsche, J</creatorcontrib><creatorcontrib>Stephens, G</creatorcontrib><creatorcontrib>Mohamed, A</creatorcontrib><creatorcontrib>Hwu, P</creatorcontrib><creatorcontrib>Yee, C</creatorcontrib><creatorcontrib>Reinhardt, C</creatorcontrib><creatorcontrib>Weinschenk, T</creatorcontrib><creatorcontrib>Gharpure, K</creatorcontrib><creatorcontrib>Stungis, A</creatorcontrib><creatorcontrib>Vining, D J</creatorcontrib><creatorcontrib>Singh, H</creatorcontrib><creatorcontrib>Walter, S</creatorcontrib><creatorcontrib>Andersson, B S</creatorcontrib><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tsimberidou, A-M</au><au>Ma, H</au><au>Stewart, C</au><au>Schoor, O</au><au>Maurer, D</au><au>Mendrzyk, R</au><au>Satelli, A</au><au>Fritsche, J</au><au>Stephens, G</au><au>Mohamed, A</au><au>Hwu, P</au><au>Yee, C</au><au>Reinhardt, C</au><au>Weinschenk, T</au><au>Gharpure, K</au><au>Stungis, A</au><au>Vining, D J</au><au>Singh, H</au><au>Walter, S</au><au>Andersson, B S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>1155PPhase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers</atitle><jtitle>Annals of oncology</jtitle><date>2018-10-01</date><risdate>2018</risdate><volume>29</volume><issue>suppl_8</issue><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Oxford University Press</pub><doi>10.1093/annonc/mdy288.028</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29 (suppl_8) |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_oup_primary_10_1093_annonc_mdy288_028 |
| source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| title | 1155PPhase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog® IMA101) in patients with relapsed and/or refractory solid cancers |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T02%3A22%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=1155PPhase%20I%20adoptive%20cellular%20therapy%20trial%20with%20ex-vivo%20stimulated%20autologous%20CD8+%20T-cells%20against%20multiple%20targets%20(ACTolog%C2%AE%20IMA101)%20in%20patients%20with%20relapsed%20and/or%20refractory%20solid%20cancers&rft.jtitle=Annals%20of%20oncology&rft.au=Tsimberidou,%20A-M&rft.date=2018-10-01&rft.volume=29&rft.issue=suppl_8&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy288.028&rft_dat=%3Coup%3E10.1093/annonc/mdy288.028%3C/oup%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/annonc/mdy288.028&rfr_iscdi=true |